본문 바로가기
KERD
논문KCI 등재

포도막염에 의한 녹내장과 원발개방각녹내장 환자에서 섬유주절제술의 성적 비교

Comparative Results of Trabeculectomy with Mitomycin C in Uveitic Glaucoma versus Primary Open-Angle Glaucoma

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류안과학

초록

목적: 포도막염녹내장에서 마이토마이신 C를 이용한 섬유주절제술의 장기 수술 성적을 원발개방각녹내장과 비교하여 조사하고 수술실패의 위험인자를 알아보고자 하였다. 대상과 방법: 영남대학교병원에서 2000년부터 2012년까지 마이토마이신 C를 이용한 섬유주절제술 시행 후 최소 1년 이상 경과관찰이가능하였던 포도막염녹내장 60안과 원발개방각녹내장 402안을 대상으로 안압, 안압하강제의 개수, 수술 후 합병증 등을 의무기록을통하여 후향적으로 조사하였다. 백내장수술을 포함하여 안과적 수술 기왕력이 있는 경우는 제외하였다. 수술 성공은 안압하강제의사용 여부와 관계없이 수술 후 안압이 15 mmHg (기준 A) 또는 18 mmHg 이하(기준 B)로 유지되는 경우로 정의하였다. 누적수술 성공률과 수술 실패의 위험인자는 Kaplan-Meier 생존분석과 Cox’s Regression Model을 이용하여 분석하였다. 결과: 포도막염녹내장군의 5년 수술 성공률은 원발개방각녹내장군에 비해 낮았지만(65.8% vs. 76.4%, 기준 B) 유의한 차이가 없었다. 하지만 생존분석에 의한 누적수술 성공률은 기준 A, B 모두에서 포도막염녹내장이 원발개방각녹내장보다 낮았다(p=0.049, 0.044). 섬유주절제술 후 저안압과 저안압황반병증의 발생은 포도막염녹내장에서 유의하게 높았다(p=0.044, 0.044). 수술 후 얕은 전방은포도막염녹내장군에서 기준 A와 B 모두에서 수술 실패의 의미 있는 위험인자로 나타났다. 결론: 포도막염녹내장에서 마이토마이신 C를 이용한 섬유주절제술의 누적수술 성공률은 원발개방각녹내장과 근소한 차이를 보여 마이토마이신 C를 이용한 섬유주절제술은 포도막염녹내장의 안압 조절을 위한 일차적 수술적 치료로 선택해 볼 수 있겠다.

Abstract

Purpose: In this study we evaluated the long-term outcomes and prognostic factors of trabeculectomy with mitomycin C (MMC) in eyes with uveitic glaucoma (UG) compared with primary open-angle glaucoma (POAG). Methods: We performed a retrospective chart review of 60 eyes with UG and 402 eyes with POAG that were followed up for at least 1 year after trabeculectomy with MMC between June 2000 and December 2012. The review included intraocular pressure (IOP), number of anti-glaucoma medications, and postoperative complications. Surgical success was analyzed using the Kaplan-Meier life-table method based on 2 definitions of successful IOP control with topical anti-glaucoma medications: Definition A (IOP ≤ 15 mm Hg) and Definition B (IOP ≤ 18 mm Hg). Risk factors for surgical failure of trabeculectomy were analyzed using the Cox proportional hazards model. Results: Success rate at 5 years after trabeculectomy was lower in UG than in POAG (65.8% vs. 76.4%, Definition B), but without significant difference. However, UG had a significantly lower cumulative probability of success than POAG based on Kaplan-Meier survival curves (p = 0.049 and 0.044, respectively). Postoperative hypotony and hypotony maculopathy was more frequent in UG (p = 0.044 and 0.044, respectively). In UG, the Cox proportional hazards model showed postoperative shallow anterior chamber was associated with surgical failure in both Definition A and B. Conclusions: Long-term results of trabeculectomy with MMC in eyes with UG showed successful IOP control similar to POAG. Trabeculectomy with MMC is a reasonable surgical option for the management of UG.

참고문헌 (37)

  1. Papadaki TG., "Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma", Am J Ophthalmol, 144, pp.62~69 (2007)
  2. Kok H., "Uveitic glaucoma", Ophthalmol Clin North Am, 15, pp.375~387 (2002)
  3. Levene RZ., "Glaucoma filtering surgery : factors that determine pressure control", Ophthalmic Surg, 15, pp.475~483 (1984)
  4. Skuta GL., "Wound healing in glaucoma filtering surgery", Surv Ophthalmol, 32, pp.149~170 (1987)
  5. Cheung JC., "Intermediate-term outcome of variable dose mitomycin C filtering surgery", Ophthalmology, 104, pp.143~149 (1997)
  6. Kitazawa Y., "Trabeculectomy with mitomycin. A comparative study with fluorouracil", Arch Ophthalmol, 109, pp.1693~1698 (1991)
  7. Perkins TW., "Trabeculectomy with mitomycin C : intermediate-term results", J Glaucoma, 7, pp.230~236 (1998)
  8. Liebmann JM., "The Glaucomas: glaucoma therapy" (1996), Mosby
  9. Noble J., "Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma", Can J Ophthalmol, 42, pp.89~94 (2007)
  10. Novak-Laus K., "Trabeculectomy with mitomycin C in glaucoma associated with uveitis", Coll Antropol, 29(Suppl 1), pp.17~20 (2005)
  11. Prata JA Jr., "Trabeculectomy with mitomycin C in glaucoma associated with uveitis", Ophthalmic Surg, 25, pp.616~620 (1994)
  12. Watson PG., "Surgery of the glaucomas", Br J Ophthalmol, 56, pp.299~306 (1972)
  13. Palmer SS., "Mitomycin as adjunct chemotherapy with trabeculectomy", Ophthalmology, 98, pp.317~321 (1991)
  14. Wright MM., "Intraoperative mitomycin-C for glaucoma associated with ocular inflammation", Ophthalmic Surg Lasers, 28, pp.370~376 (1997)
  15. Iwao K., "Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma : a retrospective cohort study", J Glaucoma, 23, pp.88~94 (2014)
  16. Kaburaki T., "Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis", Eye(Lond), 23, pp.1509~1517 (2009)
  17. Hamanaka T., "Pathological study of cases with secondary open-angle glaucoma due to sarcoidosis", Am J Ophthalmol, 134, pp.17~26 (2002)
  18. Ono T., "Postoperative flat anterior chamber : incidence, risk factors, and effect on the long-term success of trabeculectomy", Jpn J Ophthalmol, 57, pp.520~528 (2013)
  19. Bindlish R., "Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up", Ophthalmology, 109, pp.1336~1341 (2002)
  20. Greenfield DS., "Endophthalmitis after filtering surgery with mitomycin", Arch Ophthalmol, 114, pp.943~949 (1996)
  21. Jacobi PC., "Adjunctive mitomycin C in primary trabeculectomy in young adults : a long-term study of case-matched young patients", Graefes Arch Clin Exp Ophthalmol, 236, pp.652~657 (1998)
  22. Shields MB., "Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin C", Am J Ophthalmol, 116, pp.673~683 (1993)
  23. Waheed S., "Recurrent bleb infections", Br J Ophthalmol, 82, pp.926~929 (1998)
  24. Toris CB., "Aqueous humor dynamics in experimental iridocyclitis", Invest Ophthalmol Vis Sci, 28, pp.477~481 (1987)
  25. de Smet MD., "The surgical management of chronic hypotony due to uveitis", Eye(Lond), 19, pp.60~64 (2005)
  26. Jampel HD., "Hypotony maculopathy following trabeculectomy with mitomycin C", Arch Ophthalmol, 110, pp.1049~1050 (1992)
  27. Stamper RL., "Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil", Am J Ophthalmol, 114, pp.544~553 (1992)
  28. Daugeliene L., "Cataract development after trabeculectomy with mitomycin C : a 1-year study", Jpn J Ophthalmol, 44, pp.52~57 (2000)
  29. Husain R., "Effect of trabeculectomy on lens opacities in an East Asian population", Arch Ophthalmol, 124, pp.787~792 (2006)
  30. AGIS(Advanced Glaucoma Intervention Study)Investigators., "The Advanced Glaucoma Intervention Study : 8. Risk of cataract formation after trabeculectomy", Arch Ophthalmol, 119, pp.1771~1779 (2001)
  31. Lazaro C., "Lens fluorophotometry after trabeculectomy in primary open-angle glaucoma", Ophthalmology, 109, pp.76~79 (2002)
  32. Popovic V., "Course of exfoliation and simplex glaucoma after primary trabeculectomy", Br J Ophthalmol, 83, pp.305~310 (1999)
  33. Belfort R Jr., "Surgical approaches to uveitis", Int Ophthalmol Clin, 30, pp.314~317 (1990)
  34. Foster CS., "Cataract surgery and intraocular lens implantation in patients with uveitis", Ophthalmology, 96, pp.281~288 (1989)
  35. Jampel HD., "Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma", Am J Ophthalmol, 109, pp.168~173 (1990)
  36. Ophir A., "Remission of anterior uveitis by subconjunctival fluorouracil", Arch Ophthalmol, 109, pp.12~13 (1991)
  37. Weinreb RN., "Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects", Ophthalmology, 94, pp.564~570 (1987)

관련 논문AI추천

이 간행물의 다른 논문 (24건)